ES461973A1 - Procedimiento para la preparacion de benzamidatos. - Google Patents

Procedimiento para la preparacion de benzamidatos.

Info

Publication number
ES461973A1
ES461973A1 ES461973A ES461973A ES461973A1 ES 461973 A1 ES461973 A1 ES 461973A1 ES 461973 A ES461973 A ES 461973A ES 461973 A ES461973 A ES 461973A ES 461973 A1 ES461973 A1 ES 461973A1
Authority
ES
Spain
Prior art keywords
animals
antiviral agents
aromatic amidines
formula
amidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461973A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES461973A1 publication Critical patent/ES461973A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Procedimiento para la preparación de benzamidatos de la fórmula general II (Ver fórmula) en donde R1 y R2 son cada uno alcohilo de 12 a 24 átomos de carbono, R5 es un grupo alcohilo inferior y X es oxígeno y azufre, caracterizado por hacer reaccionar un compuesto de la fórmula: (Ver fórmula ) Con R5XH en donde R1, R2, R5 y H son como se ha definido antes.
ES461973A 1976-07-23 1977-08-30 Procedimiento para la preparacion de benzamidatos. Expired ES461973A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/708,180 US4025555A (en) 1976-07-23 1976-07-23 Aromatic amidines as antiviral agents in animals

Publications (1)

Publication Number Publication Date
ES461973A1 true ES461973A1 (es) 1978-06-01

Family

ID=24844709

Family Applications (2)

Application Number Title Priority Date Filing Date
ES460833A Expired ES460833A1 (es) 1976-07-23 1977-07-16 Un procedimiento para la preparacion de amidinas.
ES461973A Expired ES461973A1 (es) 1976-07-23 1977-08-30 Procedimiento para la preparacion de benzamidatos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES460833A Expired ES460833A1 (es) 1976-07-23 1977-07-16 Un procedimiento para la preparacion de amidinas.

Country Status (12)

Country Link
US (2) US4025555A (es)
JP (1) JPS589093B2 (es)
BE (1) BE857029A (es)
CA (1) CA1071203A (es)
DE (1) DE2732839A1 (es)
DK (1) DK328477A (es)
ES (2) ES460833A1 (es)
FR (1) FR2359122A1 (es)
GB (1) GB1541777A (es)
IE (1) IE45429B1 (es)
LU (1) LU77816A1 (es)
NL (1) NL176257C (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166132A (en) * 1977-08-18 1979-08-28 Pfizer Inc. Antiviral amine derivatives of glycerol and propanediols
JPS5785351A (en) * 1980-11-18 1982-05-28 Ube Ind Ltd Preparation of amidinecarboxylic acid
JPS60130561A (ja) * 1983-12-16 1985-07-12 Torii Yakuhin Kk アミジン誘導体およびそれを含む強心剤
JPS60245474A (ja) * 1984-05-18 1985-12-05 Meidensha Electric Mfg Co Ltd 正弦波発生回路
US6368324B1 (en) 1999-09-24 2002-04-09 Medtronic Xomed, Inc. Powered surgical handpiece assemblies and handpiece adapter assemblies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5246949B2 (es) * 1973-10-19 1977-11-29
JPS5331154B2 (es) * 1973-11-14 1978-08-31

Also Published As

Publication number Publication date
JPS5312834A (en) 1978-02-04
NL7708000A (nl) 1978-01-25
NL176257C (nl) 1985-03-18
DE2732839A1 (de) 1978-03-02
GB1541777A (en) 1979-03-07
US4066696A (en) 1978-01-03
LU77816A1 (fr) 1979-03-26
JPS589093B2 (ja) 1983-02-18
IE45429L (en) 1978-01-23
FR2359122B1 (es) 1980-12-05
ES460833A1 (es) 1978-04-16
FR2359122A1 (fr) 1978-02-17
NL176257B (nl) 1984-10-16
BE857029A (fr) 1978-01-23
DK328477A (da) 1978-01-21
US4025555A (en) 1977-05-24
IE45429B1 (en) 1982-08-25
CA1071203A (en) 1980-02-05

Similar Documents

Publication Publication Date Title
AR248135A1 (es) N-amino-1, 2, 4-triazinonas, su preparacion, intermediarios usados en el procedimiento, agentes antiparasitarios derivados de aminotriazinonas y el procedimiento de su obtencion.
ES8601922A1 (es) Un procedimiento para preparar derivados de pirimidina
ES2038310T3 (es) Procedimiento para la sintesis de derivados de 3-tio-4-quinolona y sus compuestos intermedios.
BG50939A3 (bg) Метод за получаване на пиридазинонови производни
FR2453175A1 (fr) Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido(4,3-b)-indoles dextrogyres
ES2040213T3 (es) Nuevos derivados de 3-oxadiazol- y 3-(ester de acido carboxilico)-beta-carbolina, su preparacion y su utilizacion como medicamentos.
ES461973A1 (es) Procedimiento para la preparacion de benzamidatos.
ES8603858A1 (es) Un procedimiento para preparar derivados de 9-aminonaftaceno
ES270293A1 (es) Un procedimiento de producir compuestos de dihidroantraceno
ES524386A0 (es) Procedimiento para la obtencion de muramilpeptidos
ES480671A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina.
ES2038282T3 (es) Metodo para producir un derivado de benzoilurea.
ES2028877T3 (es) Un procedimiento para preparar un compuesto heterociclico.
ES480603A1 (es) Un procedimiento para la preparacion de nuevos derivados de indol.
GB1185039A (en) Pyrimidine Derivatives and Compositions containing them
ES443201A1 (es) Procedimiento para preparar derivados de 5-nitroimidazol.
DE2963164D1 (en) Alpha-aminophenylacetic acid derivatives for use in the treatment of inflammations and novel alpha-aminophenylacetic acid derivatives
JPS5732274A (en) Substituted 3,5-diamino-1,2,4-oxadiazole and 3,5-diamino-1,2,4-thiadiazole, manufacture and use thereof
ES392819A1 (es) Procedimiento para la preparacion de compuestos de amino-s-triazolilbencenosulfonamida.
ATE23158T1 (de) Hexahydrodioxopyrimidine, ihre herstellung und verwendung.
ES458729A1 (es) Procedimiento de preparacion de los derivados de benzo(b)fu-rano.
ES295569A1 (es) Procedimiento para la preparación de nuevos isotiocianatos
FR2435946B1 (es)
ES281404A1 (es) Procedimiento para la preparación de difenilalquilaminas
ES461252A1 (es) Un procedimiento para la produccion de 4,5-epoxi-tetrahidro-piran-3-ona.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201